Go back

Cell Therapy Catapult strikes manufacturing deal with Loughborough

The Technology Strategy Board's Cell Therapy Catapult and Loughborough University have announced plans to work together to develop manufacturing processes for cell-based therapies.

The aim of the collaboration is to increase knowledge of how to ensure reproducibility, purity, potency and efficacy in the manufacturing process.

Catapult chief executive Keith Thompson said: “This is one of the fundamental translational gaps that the CT catapult is working to bridge, providing the cell therapy industry with important advances, and the expertise available at the [university’s Centre for Biological Engineering] will be invaluable for this task.”

This article on Research Professional News is only available to Research Professional or Pivot-RP users.

Research Professional users can log in and view the article via this link

Pivot-RP users can log in and view the article via this link.